Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Srirajan Vaidyanathan
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Related publications
Metabolism and Disposition of Tribendimidine and Its Metabolites in Healthy Chinese Volunteers
Drugs in R and D
Pharmacology
Characterization of a Novel Venetoclax Resistance Mutation (BCL2 Phe104Ile) Observed in Follicular Lymphoma
British Journal of Haematology
Hematology
Metabolic Changes Associated With Metformin Potentiates BCL-2 Inhibitor, Venetoclax, and CDK9 Inhibitor, BAY1143572 and Reduces Viability of Lymphoma Cells
Oncotarget
Oncology
Unusual Manifestation of Sweet's Syndrome in B-Cell Lymphoma
Acta Dermato-Venereologica
Dermatology
Medicine
Development and Characterization of 5 Canine B-Cell Lymphoma Cell Lines
Leukemia Research
Cancer Research
Oncology
Hematology
The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma
Cancer Discovery
Oncology
Combination of Pim Kinase Inhibitor SGI-1776 and Bendamustine in B-Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans
Therapeutic Drug Monitoring
Pharmacology
The Disposition of Antipyrine and Its Metabolites in Young and Elderly Healthy Volunteers.
British Journal of Clinical Pharmacology
Pharmacology
